Precigen (PGEN) EBT Margin Growth (3y) (2015 - 2026)
Precigen (PGEN) EBT Margin Growth (3y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
49,756.00 |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
441.00 |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
Precigen |
1.32 Bn |
1.32 Bn |
20.69 Mn |
699,954.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
699,954.00 |
| Dec 31, 2025 |
-66,976.00 |
| Jun 30, 2025 |
-7.75 Mn |
| Mar 31, 2025 |
-360,372.00 |
| Dec 31, 2024 |
-163,081.00 |
| Sep 30, 2024 |
-191,349.00 |
| Jun 30, 2024 |
-817,422.00 |
| Mar 31, 2024 |
-1.71 Mn |
| Dec 31, 2023 |
-251,043.00 |
| Sep 30, 2023 |
-198.00 Mn |
| Jun 30, 2023 |
-110,157.00 |
| Mar 31, 2023 |
-696,391.00 |
| Dec 31, 2022 |
37,242.00 |
| Sep 30, 2022 |
-17,157.00 |
| Jun 30, 2022 |
-79,984.00 |
| Mar 31, 2022 |
-20,025.00 |
| Dec 31, 2021 |
75,526.00 |
| Sep 30, 2021 |
-54,836.00 |
| Jun 30, 2021 |
-65,367.00 |
| Mar 31, 2021 |
4,925.00 |
